Anavex Life Sciences Corp (AVXL)

[nidan7500]

https://finance.yahoo.com/news/anavex-publication-supports-clinical-biomarker-110000653.html

What's missing here? Anyone w/even a minimum CNS diseases knowledge who reads this PR yesterday must have had trouble sleeping. We all know some one or some family living w/some form of a CNS disease. These are life changing facts and concepts being exchanged/defined by AVXL, on almost a daily basis. No other BioMed firm has even a fraction of the potential being discussed by AVXL.

How can the content of this PR and the current SP of AVXL be reconciled logically or rationalized to say ..."It's all good" ? It is a struggle to understand the clinical facts (a little) , then judge the consequences of the current GAPs (what could be happening vs what is actually happening). We (AVXL) are a case where the medical consequences are way out in front of the reality of daily -family life.

Is the SP gap between the clinical (potential) value expressed by this PR just too much for the average investor to understand (or get their arms around)? The reality is that massive biomed changes are planned. Are investors just saying.."NNAHHH",, cannot be true? Is AVXL just too small a fish to even keep or pay attention to? Do the rest of us just have our heads in the clouds, expecting everyone to "Get It"?? Look at the portfolio of important trials being planned or conducted right now. AVXL is "Not your Father's Oldsmobile". WAKE UP.

There has to be a way to prove this is all true....IT's REAL. The GAP between measured value and potential value is massive.